Intraocular Pressure and Anterior Segment Morphometry Changes after Uneventful Phacoemulsification in Type 2 Diabetic and Nondiabetic Patients
Table 1
Demographic and clinical characteristics of the study population.
DM group (n = 45)
Non-DM group (n = 44)
Age (y)
72.7 ± 5.7
70.6 ± 6.3
0.1061
Female (n)
28 (63%)
27 (61%)
0.9343
Right eyes (n)
22 (49%)
29 (66%)
0.1053
BMI (kg/m2)
28.2 ± 3.9
27.9 ± 5.2
0.7631
Smoking history (n)
10 (22%)
17 (39%)
0.0923
HbA1c levels (%)
6.8 ± 1.0
5.5 ± 0.4
<0.001
Duration of diabetes (y)
9.1 ± 8.0
n/a
n/a
DR stage (n)
No apparent DR
39 (87%)
n/a
n/a
Mild to moderate NPDR
6 (13%)
Oral antidiabetic agents (n)
43 (96%)
n/a
n/a
Insulin treatment (n)
7 (16%)
n/a
n/a
Axial length (mm, preoperatively)
22.9 ± 0.7
23.0 ± 0.8
0.8551
Intraoperative data
Cataract grade
1.6 ± 0.6
1.9 ± 0.6
0.032
CDE
9.3 ± 7.1
9.3 ± 6.4
0.9971
IOL power
22.1 ± 1.6
22.2 ± 1.8
0.6872
Acrysof®/Akreos®
37/8
38/6
0.5923
Data were derived from independent samples t-test1, Mann–Whitney test2, and chi-square3 test. Continuous variables are reported as mean ± standard deviation. , statistical significance. BMI, body mass index; CDE, cumulative dissipated energy; DM, diabetes mellitus; DR, diabetic retinopathy; NPDR, nonproliferative DR; IOL, intraocular lens; mm, millimeters; n/a, not applicable; y, years.